MENU
CTNM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Contineum Therapeutics (CTNM) Ownership - Who owns Contineum Therapeutics?
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need... Show more
Profile
Industry
N/A
Address
10578 Science Center Drive
Phone
+1 858 333-5280
Employees
31
Web
https://www.contineum-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
101.16M
P/E Ratio
26.40
Total Cash
204.76M
Projected Growth
N/A
Total Debt
6.26M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CTNM
Capitalization
101M
P/E Ratio
26.40
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
205M
Total Cash/Share
7.91
Total Debt
6.26M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
198M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-2.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
26K
Current Ratio
20.69
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-24.62
Shares Held By Institutions
252M
Shares Outstanding - Current
25.9M
Total Liabilities
14.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-73.686
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10578 Science Center Drive
Phone
+1 858 333-5280
Employees
31
Web
https://www.contineum-tx.com